Validea Detailed Fundamental Analysis

Validea's guru fundamental report indicates that Medtronic (MDT) scores highly (75%) using their Multi-Factor Investor model, based on Pim van Vliet's strategy of seeking low volatility stocks with strong momentum and high net payout yields; while MDT passes the market cap and standard deviation tests, it is neutral on twelve minus one momentum and net payout yield, ultimately resulting in a fail for the final rank based on this specific strategy.

Analysis

Medtronic PLC (MDT) scored 75% on Validea's Multi-Factor Investor model, which is based on Pim van Vliet's strategy targeting low volatility, strong momentum, and high net payout yield. While this score is notable, it falls below the 80% threshold that indicates strategic interest. The analysis reveals a mixed performance against the model's criteria: MDT passed on its market capitalization and standard deviation, confirming its profile as a large-cap, low-volatility security. However, it only achieved 'Neutral' ratings for 'twelve minus one momentum' and 'net payout yield', indicating a lack of strength in these two key factors. Consequently, despite its favorable low-risk characteristics, the stock ultimately received a 'FAIL' on its final rank within this specific quantitative framework.

Key Decisions for Investors

• Investors prioritizing low volatility may find MDT's 'PASS' on the standard deviation metric appealing, but should weigh this against its neutral momentum and yield profile.
• Given the 'FAIL' rating from this multi-factor model, investors should scrutinize the stock's momentum indicators and net payout yield before initiating or adding to a position.
• Treat this quantitative screen as one input; the 'FAIL' highlights specific factor weaknesses rather than a fundamental flaw in the company, warranting a broader analysis beyond this single model's constraints.